GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹3,625 Cr | ₹4,401 Cr | ₹3,463 Cr | ₹2,633 Cr | ₹2,633 Cr |
What is the latest Revenue of GLAND PHARMA ?
Year | Revenue |
---|---|
Mar2024 | ₹3,625 Cr |
Mar2023 | ₹4,401 Cr |
Mar2022 | ₹3,463 Cr |
Mar2021 | ₹2,633 Cr |
Mar2020 | ₹2,633 Cr |
How is Revenue of GLAND PHARMA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹3,625 Cr | -17.64 | |
Mar2023 | ₹4,401 Cr | 27.08 | |
Mar2022 | ₹3,463 Cr | 31.51 | |
Mar2021 | ₹2,633 Cr | 0.00 | |
Mar2020 | ₹2,633 Cr | - |
Compare Revenue of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹25,583.6 Cr | 1.9% | 3.5% | -11.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,430.0 Cr | -3% | -8.7% | 4.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,410.0 Cr | -4.7% | -4.5% | 58.5% | Stock Analytics | |
CIPLA | ₹113,950.0 Cr | -4.3% | -3.2% | -3.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹99,682.3 Cr | -3% | -12.3% | 13.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,261.6 Cr | -3% | -6.5% | -12.7% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | 1.9% |
3.5% |
-11.2% |
SENSEX | -3.4% |
-4.4% |
0.6% |
You may also like the below Video Courses